Koreans are much interested in various kinds of healthy food and stamina-related products such as prescription drugs for erectile dysfunction.Especially after the release of Viagra (ingredient name: Sildenafil) in Korea, the domestic market of drugs for erectile dysfunction has sharply grown. Beside
The Korean pharmaceutical industry is keeping their eyes and ears on the US president Donald Trump.The main point of his healthcare policy is to decrease medical budget and provide the largest benefits to Americans in accordance with ‘America first’ policy. But because of his political uncertainty,
The IMPC Conference in Seoul, January 19th contributed many key speakers with big names such as John Sculley, (former presidents of Pepsi-Cola and Apple Inc) Dr. Andrew von Eschenbach, (Commissioner of the United States Food and Drug Administration) and Dr. John Hariri (the founder and CEO of Celgen
The first IPMCC (International Precision Medicine Center Conference) was held on the 19th of January at the Westin Chosun Hotel, Seoul to discuss global insights of state-of-the-art precision medicine and medical technology research, development, clinical application and digital health. Its theme wa
Crisis hits Daegu-Gyeongbuk Medical Innovation Foundation and Osong Bio Promotion Foundation as both foundations, built on 492.7 billion won of government funds, are on the verge of shutting down.An audit performed by the Board of Audit and Inspection revealed that the 2 foundations were severely mi
Foreign doctors can treat patients if they get a doctor’s license in Korea, which isn’t applied to doctors from all countries. They have to graduate from medical colleges the Ministry of Health and Welfare admits and to get the doctor’s license in their countries. Then, they are qualified to take th
[By Du-hyeon Nam, KBMBR]The Korea Institute for Industrial Economics & Trade (KIET) analyzed that Japan pays attention to Korean strategy to build a bio industry complex in ‘Check on oversea industry (Mok Sagong/researcher)’. Japan is actively developing biosimilar as an alternative to cope with sha
[by Seong-sun Gwak, KBMBR] Chin-youb Chung, minister of health and welfare attended OECD health minister’s meeting and talked about the way to export Korean healthcare system such as telemedicine etc. In the OECD meeting held in Paris, France on the 17th, OECD Secretary-General Angel Gurria,
[by Constance Williams, KBMBR]When you step off the escalator that leads you to the front desk of Yonsei Severance Hospital, you can’t help but tilt your head back and admire the orientation and organization of architectural elements on the landscape through its sloping walls and state-of-the-art LE
[by Du-hyeon Nam, KBMBR]Paju city announced it would make the world’s largest bio medical industrial complex based on precision medicine such as cell therapy.Deputy mayor Jun-tae Kim (acting mayor) said in the 1st international precision medicine center conference hosted by IPMC (International Preci
[by Du-hyeon Nam, KBMBR]The government prepared for a supportive measure for medical institutions to go abroad with the law of Act on support for overseas expansion of healthcare system and attraction of international patients. Recently, it suggested a guideline that the institutions have to check.T
[by Gi Taek Park, KBMBR]Experts released the statement about Statin that has caused the possible outbreak of diabetes when people take it for a long time. According to the statement, if Statin isn’t prescribed to patients with hyperlipidemia etc., the risk of the outbreak of diabetes can increase. R
[by Hye-seon Lee, KBMBR]The CJ Healthcare’s plan to secure money for investment through listing reached a deadlock. CJ Healthcare selected NH INVESTMENT & SECURITIES and SHINHAN INVESTMENT as major companies and has been pushing for IPO (Initial Public Offering) for listing in the first half of last
[by Hye-seon Lee , KBMBR]Yonsei university-industry foundation said that it transferred the patent right about ‘Neural precursors from human embryonic stem cells for curing CNS defect’ to the cell therapy product company, S.BIOMEDICS (CEO Dong-ho Kang).The technology was initiated by Prof. Dong-wook
[by Constance Williams, KBMBR]AMC (also known as Seoul Asan Hospital) in Jamsil towered over me, gleaming in pearly white as I made my way through the endless corridors. Being the largest medical institution in Korea with a total of 2,700 beds and more than a thousand doctors, it’s easy to say that
[by Du-hyeon Nam, KBMBR]Some bio and pharmaceutical companies whose stock prices drop range were large last year started smoothly in the beginning of this year, which makes investors have expectation.KBMBR (Korea Bio Medical Business Review) analyzed price earnings ratio for the week from 30th Decem
[by Constance Williams, KBMBR]Green Cross LabCell got the patent to make mass production of the cell therapy product.The company (CEO Bok-soo Park) announced on the 13th it got the patent about the cultivation method of the natural killer cell using T-cell from the Korea Intellectual Property Office
[by Na young Choi, KBMBR]About 300,000 foreign patients visited Korea in 2015.According to the Korea Health Industry Development Institute, foreign patients who visited Korea in 2015 were 297,000, up 11.4% from a year earlier. Since 2009, the increase rate of foreign patients who visited Korea has i
[by Constance Williams, KBMBR]In the summer of 2016, a team assembled at the Royal College of Surgeons in London for one of the most special medical procedures: A post mortem (after death). But there is a difference in this post mortem: the team was specifically looking at how obesity affected the b
[by Du-hyeon Nam, KBMBR]Last year, the amount of money for export and import of pharmaceutical products exceeded $2billion and $5billion respectively for the first time since 2000.According to the results of import and export (based on the date of registration processed), the amount of money for imp